Compound tracker

Mescaline.

A source-backed research page for trial rows and update notes connected to this compound or investigational product. The page is generated from the Notion tracker and should be read as a living research map, not a medical conclusion.

2 trial rows 0 update rows Latest checked: Jan 24, 2024 All trials
Claim boundary

Trial registration, company topline, CNPV/rolling-review status, recruitment status, public-dashboard data, or review literature do not equal approval, label, reimbursement, access, safety, or efficacy. Check each source note before turning a row into a claim.

Backlinks

This page links out to registry/source records, the global trial tracker, the updates feed, and matching wiki dossiers when available.

2
Trial rows
Phase 1
Phases tracked
Completed
Statuses seen
NCT04227756 Phase 1 Completed updated Jan 24, 2024

Comparative Acute Effects of LSD, Psilocybin and Mescaline

Condition
Healthy
Sponsor / institution
University Hospital, Basel, Switzerland
Start date
May 19, 2020
Tracker note / source boundary

ClinicalTrials.gov v2 sync on 2026-04-10 | Overall status: COMPLETED | Exact phase: Phase 1 | Lead sponsor: University Hospital, Basel, Switzerland | Conditions: Healthy

No source-update rows are currently linked to this compound.
Healthy